TMPRSS2 and prostate carcinoma: Commercially available purified recombinant ERG protein, established prostate cancer cell lines VCaP (TMPRSS2-ERG fusion positive) and LNCaP (TMPRSS2-ERG fusion negative), and female urine were used to prepare three types of samples mimicking cell lines, tissues, and urine sediments for the analysis.